Physician profile
Emily M Schehlein
NPI 1538692421
$43,776.49
in general payments reported to CMS, 2019-2025
13 companies · $16K in 2025
The $16K reported for 2025 was more than what 95% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,285 · 2023: $2,637 · 2024: $23K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $4,342 · Food and Beverage: $4,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,694.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,300.00 |
| Travel and Lodging | $4,341.53 |
| Food and Beverage | $4,155.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $24,951.70 | 2022-2025 | Hydrus Microstent, Voyager Dslt, Clareon |
| Glaukos Corporation | $8,397.16 | 2023-2025 | Idose, Idose Tr, Idosetr |
| Abbvie INC. | $4,387.31 | 2023-2025 | Xen Glaucoma Treatment System, Durysta |
| Alcon Research LLC | $2,600.00 | 2025 | Viscoat |
| Nova Eye, INC. | $1,732.66 | 2025 | |
| Allergan, INC. | $1,122.16 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $226.35 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $193.91 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Rayner Intraocular Lenses Limited | $41.96 | 2025 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Dompe US, INC. | $39.47 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $36.11 | 2023 | |
| Bausch & Lomb Americas INC. | $33.87 | 2025 | |
| New World Medical,INC. | $13.83 | 2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Schehlein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.